Form 4: TAO Synergies Chief Medical Officer Reports Routine Equity Compensation and Tax Withholding

TAO Synergies Inc.'s Chief Medical Officer and Director, Alan J. Tuchman, reported the immediate vesting of 4,315 restricted stock units and the subsequent withholding of 1,726 shares for tax purposes on June 30, 2025.

Summary

• Alan J. Tuchman, Chief Medical Officer and Director of TAO Synergies Inc., reported changes in his beneficial ownership of company common stock.
• On June 30, 2025, 4,315 restricted stock units (RSUs) were granted to Mr. Tuchman under the Issuer's 2020 Equity Incentive Plan.
• These 4,315 RSUs vested immediately upon issuance.
• Following the RSU grant, Mr. Tuchman's beneficial ownership included these 4,315 RSUs and 1,320 previously held shares, totaling 5,635 shares.
• Concurrently, 1,726 shares were withheld by TAO Synergies Inc. at a price of $7.85 per share to satisfy tax liabilities related to the RSU vesting.
• This withholding of shares for tax purposes does not constitute an actual sale or other open-market transaction.
• After these transactions, Alan J. Tuchman beneficially owns 3,909 shares of TAO Synergies Inc. common stock.

Sentiment

Score: 6

Explanation: The document reports a routine insider transaction involving the grant and immediate vesting of restricted stock units as executive compensation, followed by a standard tax withholding. This is generally a neutral event, but the immediate vesting and ongoing equity compensation program can be seen as a positive for management alignment.

Positives

• Immediate vesting of 4,315 restricted stock units (RSUs) for the Chief Medical Officer, indicating a direct incentive and retention mechanism.
• The grant of RSUs under the 2020 Equity Incentive Plan suggests ongoing use of equity compensation to align management interests with shareholders.

Negatives

• A reduction in direct beneficial ownership by 1,726 shares due to shares being withheld to cover tax liabilities, which is a common practice but reduces the insider's direct stake.

Risks

• NA

Future Outlook

NA

Industry Context

NA

Related Party Transactions

• Grant of 4,315 restricted stock units to Chief Medical Officer Alan J. Tuchman under the Issuer's 2020 Equity Incentive Plan.
• Withholding of 1,726 shares by the Issuer to satisfy tax liability upon vesting of restricted stock units for Alan J. Tuchman.

Stakeholder Impact

• Shareholders: The grant of RSUs represents a form of equity compensation that aligns management's interests with shareholder value, although it involves a minor dilutive effect.
• Employees: The transaction demonstrates the company's use of equity incentive plans as part of its compensation strategy for key personnel.

Key Dates

Keywords

TAO Synergies Inc., TAOX, Form 4, Insider Transaction, Beneficial Ownership, Restricted Stock Units, Equity Incentive Plan, Executive Compensation, Chief Medical Officer, Director, Stock Transaction, Tax Withholding